Ribosomal protein S17 pseudogene 16 (RPS17P16)

RPS17P16 refers to a processed pseudogene related to ribosomal protein S17. Pseudogenes are copies of genes that have accumulated mutations rendering them nonfunctional; they are generally not transcribed into functional proteins and do not play a direct role in cellular processes. RPS17P16 does not encode a functional ribosomal protein and, as such, is not considered a therapeutic target or druggable receptor/enzyme. Its name reflects its origin from the functional *RPS17* gene, which encodes a protein of the cytoplasmic 40S ribosomal subunit essential for protein synthesis[2][7]. This pseudogene is not associated with any known direct biological function, disease role, or clinical biomarker utility, nor does it interact with any drugs. Pseudogenes like RPS17P16 are generally regarded as non-functional "genomic fossils" and are distinct from their protein-coding parents[1][3]. The canonical parent gene, *RPS17*, plays an essential role in ribosome structure and protein translation, and its mutations can be disease-causing, but RPS17P16 itself does not[5]. RPS17P16 should not be confused with functional targets such as "40S ribosomal protein S17" (*RPS17*)[3][5]. No evidence supports its use as a therapeutic target or relevance for drug interaction or patient biomarker strategies.

Other names

RPS17_8_1748RPS17P16